N/A N=26 Randomized Treatment

Transcutaneous Electrical Nerve Stimulation After Total Knee Arthroplasty.

Transcutaneous Electric Nerve Stimulation · Pain

Bottom Line

View on ClinicalTrials.gov: NCT03046225 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2018

Primary outcome: Primary: Change in Pain Level From Baseline to 90 Minutes — 3.1; 3.3 Units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Transcutaneous electrical nerve stimulation (Device); Continuous passive movement device (Device); Exercises (Other)
Age: Adult, Older Adult · 40+ yrs
Sex: All
Sponsor: Hospital de Clinicas de Porto Alegre
Primary completion: Sep 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Pain Level From Baseline to 90 Minutes	3.1; 3.3	—
SECONDARY Number of Participants Who Received Morphine Within 24 Hours	6; 8	—
SECONDARY Change in Knee Range of Motion From Baseline to 30 Minutes	46.2; 44.9	—

Summary

Total knee arthroplasty (TKA) consists of a surgical replacement of this joint by a prosthesis, and it is mainly carried out in cases of knee osteoarthrosis. In the postoperative period of TKA, the pain is intense and limits the mobility of patients, so the analgesia is one of the goals of the physical therapy. One of the alternatives available for pain management is the transcutaneous electrical nerve stimulation (TENS), characterized by the application of an electric pulsed current through electrodes positioned on the skin. Therefore, the present study aims to evaluate the acute effects of TENS associated with conventional physical therapy compared with conventional physical therapy on the pain level, knee range of motion and administration of morphine in the rehabilitation of patients after TKA.

Eligibility Criteria

Inclusion Criteria

Patients who underwent TKA surgery due to primary or secondary gonarthrosis; Both sexes; Age between 40 and 90 years.

Exclusion Criteria

Patients who refused to participate of the study; Indication of TKA for fractures and bone tumors; TKA review surgery; Infection during the postoperative period; Congenital anatomical alterations; Neurological disorders; Lack of understanding of commands; Sensitivity alterations in the lumbar spine or lower limbs; Decompensated heart disease or cardiac pacemaker use.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03046225). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.